Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders Among Hospitalized Patients

Launched by COLUMBIA UNIVERSITY · Jan 17, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how well a special care team can help hospitalized patients who have serious infections from injecting drugs and also struggle with substance use disorders. The main goal is to find out if this integrated approach can help patients live longer and reduce the number of times they have to return to the hospital. If you are over 18 years old, currently in a hospital for a severe injection-related infection, and have used injected drugs in the past year, you might be eligible to participate in this trial.

If you join the study, you will receive care from a dedicated team that focuses on both your infection and substance use issues. Researchers will compare your health outcomes with those of patients receiving standard treatment. Participation will involve providing informed consent and attending follow-up visits to track your recovery. It’s important to remember that individuals with serious cognitive impairments, those currently in jail, or those unable to give consent will not be eligible for the study. This trial aims to improve care for people facing both severe infections and addiction challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Be admitted to a participating hospital at the time of randomization
• • Be 18 years of age or older
• • Currently be experiencing a severe injection-related infection/SIRI or suspected SIRI
• • Have an indication of injecting drugs in the prior year
• • Provide informed consent
• • Ability to communicate in English
• • Provide sufficient locator information
• • Sign a HIPAA form and/or EHR release to facilitate record abstraction
• • Report being willing to return for follow-up visits
• Exclusion Criteria:
• All individuals meeting any of the exclusion criteria will be excluded from study participation. Specifically, individuals will be excluded from participation if they:
• • have significant cognitive or developmental impairment to the extent that they are unable to provide informed consent
• • (or their legal guardian/representative) are unable or unwilling to give written informed consent
• • are currently in jail, prison or other overnight facility as required by court of law or have pending legal action that could prevent participation in study activities
• • are terminated via site principal investigator decision with agreement from one of the study lead investigators.